Investigational new drug: Difference between revisions

From DISI
Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes.
An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes.


An IND filing with the [[FDA]] is required before starting [[clinical testing]].
An IND filing with the [[FDA]] is required before starting [[clinical trials]].
 
 
[[Category:Jargon]]

Latest revision as of 18:04, 15 February 2014

An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes.

An IND filing with the FDA is required before starting clinical trials.